illuminate studyilluminate study

The ILLUMINATE Study—a study to learn more about an investigational drug for Rett syndrome

Are you or someone you care for living with Rett syndrome? You might be interested in the ILLUMINATE Study, which is testing an oral medication and any effects it may have on symptoms like sleep, communication, and seizures in those living with Rett syndrome.

About the ILLUMINATE Study

About the ILLUMINATE Study

Rett syndrome is a rare, lifelong condition that affects females more frequently than males. It is usually linked to changes in the MECP2 gene. While researchers have learned a lot, there’s still more to understand about Rett syndrome. The ILLUMINATE Study aims to learn more about an investigational drug and any effects it may have on symptoms (including sleep, communication, and seizures).

Read more
See If You Qualify

See If You Qualify

Joining a clinical study can support efforts to better understand Rett syndrome and may help improve care and treatment options for others in the future.

Read more
study volunteers

The most important people in clinical research are study volunteers.

The contributions of participants and caregivers make clinical studies like the ILLUMINATE Study possible.

Why the ILLUMINATE Study?

The ILLUMINATE Study is important because Rett syndrome has a profound impact on those affected, leading to physical, communication, and cognitive challenges, and often places substantial emotional and caregiving challenges on families. The results of this study will help us understand Rett syndrome and may help others in the future.